司他夫定、拉米夫定和茚地那韦用于晚期HIV-1感染儿童：初步经验。 - Suppr

Suppr

超能文献

Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.

作者信息

Monpoux F, Sirvent N, Cottalorda J, Mariani R, Lefbvre J C

出版信息

AIDS. 1997 Oct;11(12):1523-5.

PMID:9342078

Abstract

摘要

相似文献

Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.

AIDS. 1997 Oct;11(12):1523-5.

[Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].

An Med Interna. 2003 May;20(5):239-42.

Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.

J Infect Dis. 2000 Sep;182(3):950-4. doi: 10.1086/315753. Epub 2000 Aug 17.

Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.

Antivir Ther. 2005;10(8):911-6.

Study shows three drugs better than two.

AIDS Alert. 1997 Apr;12(4):39.

ACTG 320 trial halted as three-drug arm proves superior.

AIDS Patient Care STDS. 1997 Jun;11(3):194.

AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.

AIDS. 2000 Mar 10;14(4):367-74.

Undetectable HIV levels after triple therapy with indinavir.

AIDS Patient Care STDS. 1997 Jun;11(3):193-4.

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):464-71. doi: 10.1097/00126334-200212150-00002.

3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.

BETA. 1997 Mar:3-4.

引用本文的文献

Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children.

Antimicrob Agents Chemother. 2004 May;48(5):1904-7. doi: 10.1128/AAC.48.5.1904-1907.2004.

Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children.

Antimicrob Agents Chemother. 2001 Mar;45(3):701-5. doi: 10.1128/AAC.45.3.701-705.2001.

Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection.

Antimicrob Agents Chemother. 2000 Mar;44(3):752-5. doi: 10.1128/AAC.44.3.752-755.2000.

Indinavir: a review of its use in the management of HIV infection.

Drugs. 1999 Dec;58(6):1165-203. doi: 10.2165/00003495-199958060-00011.

Stavudine: an update of its use in the treatment of HIV infection.

Drugs. 1999 Nov;58(5):919-49. doi: 10.2165/00003495-199958050-00012.

A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodeficiency virus-infected patients.

Antimicrob Agents Chemother. 1999 Mar;43(3):647-50. doi: 10.1128/AAC.43.3.647.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验